XO1 acquired by Janssen Pharmaceutical Companies of Johnson & Johnson
Please follow and like us:
Confluence Tax is delighted to have assisted XO1 with its sale to Janssen Pharmaceuticals.
Commenting on our role, Richard Mason, CEO of XO1, said:
“Confluence Tax LLP are clearly streets ahead of everybody, including the big 4 firms, when it comes to providing professional taxation advice in the biotech space”.
